1-3 of 3
Samantha M. Jaglowski
Close
Sort by
Journal Articles

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

Clinical Trials & Observations
Adam S. Kittai, David A. Bond, Basem William, Ayman Saad, Sam Penza, Yvonne Efebera, Karilyn Larkin, Sarah A. Wall, Hannah K. Choe, Bhavana Bhatnagar, Sumithira Vasu, Jonathan Brammer, Polina Shindiapina, Meixiao Long, Alice Mims, Lynn O’Donnell, Seema A. Bhat, Kerry A. Rogers, Jennifer A. Woyach, John C. Byrd, Samantha M. Jaglowski
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4648–4652.
https://doi.org/10.1182/bloodadvances.2020002783
Published: 2020
Journal Articles

How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD

Clinical Trials & Observations
Samantha M. Jaglowski, Bruce R. Blazar
Journal: Blood Advances
Blood Adv (2018) 2 (15): 2012–2019.
https://doi.org/10.1182/bloodadvances.2018013060
Published: 2018
Journal Articles

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib

Clinical Trials & Observations
Cecelia R. Miller, Amy S. Ruppert, Nyla A. Heerema, Kami J. Maddocks, Jadwiga Labanowska, Heather Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber L. Gordon, Jeffrey A. Jones, Joseph M. Flynn, Samantha M. Jaglowski, Leslie A. Andritsos, Kristie A. Blum, Farrukh T. Awan, Kerry A. Rogers, Michael R. Grever, Amy J. Johnson, Lynne V. Abruzzo, Erin K. Hertlein, James S. Blachly, Jennifer A. Woyach, John C. Byrd
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1584–1588.
https://doi.org/10.1182/bloodadvances.2017007302
Published: 2017
Includes: Supplemental data